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It has been conﬁrmed that respiratory virus infections can induce abberant cytokine
production in the host. These cytokines may be associated with both elimination of the
virus and complications in the host, such as virus-induced asthma. Representative host
defense mechanisms against pathogens, including bacteria and viruses, are mediated
by the innate immune system. Cells of the innate immune system express essential
molecules, namely pattern recognition receptors (PRRs), such as Toll-like receptors,
nucleotide-binding oligomerization domain-like receptors, and retinoic acid-inducible gene-
I-like receptors. These PRRs can recognize components of pathogens such as bacterial
lipopolysaccharide, viral antigens, and their genomes (DNA and RNA). Furthermore, PRRs
activate various signaling pathways resulting in cytokine production against pathogen
infection. However, the exact mechanisms remain unknown. In this review, we mainly
focus on the representative mechanisms of cytokine production through PRRs and
signaling pathways due to virus infections, including respiratory virus infections. In addition,
we describe the relationships between respiratory infections and virus-induced asthma.
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INTRODUCTION
Coordination between innate and adaptive immunity against
pathogens is indispensable in higher organisms including humans
(Medzhitov, 2007). In particular, innate immunity plays a critical
role during primary infection with various bacteria and viruses
(Barbalat et al., 2011; Jarchum and Pamer, 2011; Kumar et al.,
2011). The speciﬁc recognition of microorganisms may represent
the basis of innate immunity (Barbalat et al., 2011; Jarchum and
Pamer,2011; Kumar et al., 2011). Speciﬁc recognition systemshave
gradually been clariﬁed and the common platforms are Toll-like
receptors (TLRs), the NLR family (nucleotide-binding oligomer-
ization domain-like receptors), and the RLR family [RIG (retinoic
acid-inducible gene)-I-like receptors] (Kumar et al., 2011; Yu and
Levine, 2011). These molecules are called pattern recognition
receptors (PRRs). PRRs can recognize lipopolysaccharides (LPS),
viral antigens, and bacterial/viral genomes, leading to the activa-
tion of intrinsic signaling pathways (e.g., myeloid differentiation
factor 88; MyD88) and the production of various cytokines (Bar-
balat et al., 2011; Jarchum and Pamer, 2011; Kumar et al., 2011;
Ting Tan et al., 2013). The production of such cytokines may acti-
vate leukocytes and eliminate the infective agents (Chehadeh and
Alkhabbaz, 2013; Ting Tan et al., 2013).
At present, over 50 cytokines have been discovered. They form
networks and play pivotal roles in infectious and allergic dis-
eases (Barnes, 2008; Desai and Brightling, 2012; Holgate, 2012).
These cytokines are mainly produced by blood cells, lymphoid tis-
sues, and epithelial cells. For example, interferons (IFNs), which
are anti-viral cytokines produced by lymphocytes and epithelial
cells, are dramatically induced by various viral infections such
as inﬂuenza (Qin et al., 2011b; Högner et al., 2013; Lopušná
et al., 2013). This induction may contribute to the elimination of
viruses in vivo. Indeed, we use recombinant IFNs to treat chronic
viral infections such as hepatitis C (Nagao et al., 2012; Slim and
Afridi, 2012). On the other hand, aberrant induction of other
cytokines such as interleukin (IL)-4 may induce various aller-
gic diseases, such as virus-induced asthma (Baraldo et al., 2012;
Krishnamoorthy et al., 2012). In addition, aberrant induction and
an imbalance of various proinﬂammatory cytokines, for example,
IL-1β, IL-6, and tumor necrosis factor (TNF), may induce severe
systemic inﬂammatory response syndrome (Watanabe et al., 2003;
Xu et al., 2012). Thus, various cytokinesmay be associatedwith the
pathophysiology of inﬂammation and remodeling of the airways
post-infection.
Acute respiratory illnesses (ARI) are the most common diseases
in humans. Accumulating evidence suggests that around 80% of
the causative agents of ARI may be respiratory viruses (Heymann
et al., 2004; Fujitsuka et al., 2011). The prognosis is good in most
patients with viral ARI; however, viruses causing ARI may be
responsible for more severe diseases like bronchitis, bronchioli-
tis, and pneumonia (Domachowske and Rosenberg, 1999; Sigurs,
2002; Kusel et al., 2007). Furthermore, representative respiratory
viruses such as respiratory syncytial virus (RSV) may induce bron-
chiolitis or pneumonia with wheezing in infants (Stein et al., 1999;
Sigurs et al., 2000).
To better understand host defense mechanisms against viruses,
it is important to clarify these molecular mechanisms. In this
review, we focus on cytokine production and signaling pathways
during viral infection. We also discuss the relationships between
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cytokine proﬁles and virus-induced asthma under the main theme
“virus-induced asthma.”
INFECTION AND INNATE IMMUNITY
Host defense mechanisms against microbial infections constitute
the main purpose of innate immunity (an archaic term mean-
ing natural resistance; Jarchum and Pamer, 2011; Kumar et al.,
2011). The main platforms of the molecular groups against the
pathogens include TLRs, the NLR family (nucleotide-binding
oligomerization domain-like receptors), and the RLR family
(RIG-I-like receptors). These molecules/receptors can recognize
various components including LPS derived from bacteria, viruses,
and fungi, viral antigens, and the pathogen genomes (Barbalat
et al., 2011; Jarchum and Pamer, 2011; Kumar et al., 2011; Yu
and Levine, 2011). Subsequent events activate innate immu-
nity involved in cytokine production in the host (Barbalat et al.,
2011; Kumar et al., 2011; Yu and Levine, 2011; Ting Tan et al.,
2013). The innate immune system initiates a different mech-
anism against each pathogen (Chehadeh and Alkhabbaz, 2013;
Kemp et al., 2013). Thus, these pathogen-associated receptors
are called “PRRs” (Kawai and Akira, 2007; Pang and Iwasaki,
2012). Schematic illustrations of these families are shown in
Figure 1.
TOLL-LIKE RECEPTORS
As already mentioned, virus infections can induce the production
of various cytokines (Yoshizumi et al., 2010; Ishioka et al., 2011;
Kato et al., 2011). TLRs may be responsible for cytokine produc-
tion in bacteria- or virus-infected epithelial cells and immune cells
(Rudd et al., 2005; Barbalat et al., 2009). In general, it is thought
that TLRs play pivotal roles in innate immunity against viral and
bacterial infections (Kawai and Akira, 2011; McIsaac et al., 2012).
In humans, 10 types of TLRs have been identiﬁed (Akira et al.,
2006; Takeuchi and Akira, 2009; Kumar et al., 2011). TLRs pos-
sess an extracellular domain containing leucine-rich repeats and a
Toll/IL-1 receptor-like structure as the intercellular domain (TIR
domain; Janssens and Beyaert, 2003; Akira et al., 2006). TLRs can
be classiﬁed into three types: lipid ligands (TLR1, 2, 4, 6, and
10), protein ligands (TLR5), and nucleic acid ligands (TLR3 and
7–9; Janssens and Beyaert, 2003; Akira et al., 2006; Vandevenne
et al., 2010). Thus, the TLR family can recognize various biological
components derived from microorganisms (Janssens and Beyaert,
2003; Akira et al., 2006;Vandevenne et al., 2010). TLR1, 2, 4, 5, and
6 are transmembrane proteins (Janssens and Beyaert, 2003; Akira
et al., 2006; Vandevenne et al., 2010), which mainly bind to bac-
terial components such as bacterial triacylpolypeptides (TLR1),
ribopeptides (TLR2), LPS (TLR4), and the bacterial protein
FIGURE 1 | A schematic illustration of microbial infection and innate
immunity-related molecules.TLR, RLR, NLR are all expressed on and in a
variety of cells in host tissues that recognize a diverse range of microbial
signatures. The ectodomain of theTLR consists of leucine-rich repeats. Upon
ligand stimulation, all TLRs except TLR3 recruit the adaptor MyD88. TLR3 is
activated via the adaptor protein TRIF (Toll/IL-1 receptor domain containing
adaptor protein inducing interferon-1β). RLRs consist of a group of cytosolic
RNA helicases. RIG-I and MDA5 are composed of two amino-terminal CARD
domains and a central helicase domain. In contrast to RIG-I, MDA5 lacks
the C-terminal repressor domain. NLR are composed of a central
nucleotide-oligomerization domain and a C-terminal leucine-rich repeat
domain involved in the recognition of pathogens. The N-terminal domain can
be either a CARD or a PYD domain. The NLR subfamily is characterized by an
N-terminal PYD domain. ASC, apoptosis-associated speck-like protein
containing caspase recruitment domain; CARD, caspase recruit domains;
MDA, melanoma differentiation-associated protein; MyD88, myeloid
differentiation factor 88; NALP, NACHT, LRR and PYD domains-containing
protein; NOD, nucleotide-binding oligomerization domain; PYD, pyrin domain;
RIG, retinoic acid-inducible gene; TIR, Toll/IL-1 receptor-like structure as
intercellular domain; TIRAP, TIR domain-containing adaptor protein; TLR, Toll
like receptor; TRAM,TRIF-related adaptor molecule; TRIF, TIR
domain-containing adaptor including IFN-1β.
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ﬂagellin (TLR5; Janssens and Beyaert, 2003; Akira et al., 2006;
Vandevenne et al., 2010). Interestingly, TLR4 proteins also bind to
a major viral antigen of RSV F (fusion) protein (See and Wark,
2008; Klein Klouwenberg et al., 2009). In addition, TLR3, 7, 8,
and 9 reside in the endosomes in cells (Janssens and Beyaert,
2003; Akira et al., 2006; Vandevenne et al., 2010). TLR7 and 8
can recognize single strand viral RNA molecules, while TLR3
can also recognize double strand RNA and poly I:C (polyinosinic
polycytidylic acid; Janssens and Beyaert, 2003; Akira et al., 2006;
Vandevenne et al., 2010). Thus, TLR3, 7, and 8 are essential
receptors for many types of RNA viruses including paramyx-
oviruses (Sendaivirus) and orthomyxovirus (inﬂuenza viruses;
Melchjorsen et al., 2005; Hammerbeck et al., 2007; KleinKlouwen-
berg et al., 2009). Moreover, TLR9 recognizes CpG DNA (a
phosphodiester bond within cytosine and guanine; Janssens and
Beyaert, 2003; Akira et al., 2006; Vandevenne et al., 2010). Thus,
TLRs can bind to various components of microorganisms includ-
ing viruses, leading to cytokine production through activation
of signaling pathways in pathogen-infected cells (Janssens and
Beyaert, 2003; Akira et al., 2006; Vandevenne et al., 2010). An
illustrated summary is shown in Figure 2.
TLRs-ASSOCIATED SIGNALING PATHWAYS AND CYTOKINE
PRODUCTION
A summarized illustration is shown in Figure 3. TLRs possess a
common TIR domain (Janssens and Beyaert, 2003; Akira et al.,
2006). The TIR domain can bind an adaptor molecule, MyD88
(Picard et al., 2011). MyD88 triggers downstream signaling path-
ways such as IRAK (IL-1 receptor-associated kinase)-1/4, TRAF6
(TNF receptor associated factor 6), IRF (interferon regulatory fac-
tor), and/or NF-κB (Akira, 2003; Takeda and Akira, 2004). These
signals may lead to the production of various cytokines such as
type I IFN (IFN-α and -1β) and proinﬂammatory cytokines (TNF-
α, IL-1, IL-6, and IL-8; Akira, 2003; McGettrick and O’Neill, 2004;
Takeda and Akira, 2004). Thus, the pathways are called “MyD88-
dependent pathways” (Akira, 2003; McGettrick and O’Neill, 2004;
Takeda and Akira, 2004). Signaling pathways fromTLR1, 2, 5–
10 may be dependent on MyD88 (Akira, 2003; McGettrick and
O’Neill, 2004; Takeda and Akira, 2004). However, TLR3 signaling
pathways appear independent of MyD88 (Akira, 2003; McGet-
trick and O’Neill, 2004; Takeda and Akira, 2004). TLR4-mediated
pathway may involve both MyD88-dependent and -independent
pathways. With the exception of MyD88, four types of molecules
in the cells have been conﬁrmed as TIR domain-containing
molecules, including TIRAP (TIR domain-containing adaptor
protein), TRIF (TIR domain-containing adaptor including IFN-
1β)/TICAM-1 (TIR domain containing adaptor molecule-1),
TRAM (TIRF-related adaptor molecule), and SARM (sterile alpha
motif and Armadillo motif domain-containing protein). Of these,
TIRAP may be associated with MyD88, while IFN production
by TRIF/TICAM-1 of TLR4 is independent of MyD88 (Akira,
2003; McGettrick and O’Neill, 2004; Takeda and Akira, 2004).
These results suggest that the signaling pathways of each TLR
are unique and complicated (Janssens and Beyaert, 2003; Akira
et al., 2006). Nucleic acids (DNA or RNA) derived from pathogens
induce the production of cytokines (Akira, 2003; Barbalat et al.,
2011). Thus, TLRs can induce various cytokines against infections
through activation of the signaling pathways. For example, TLR4
FIGURE 2 | A summarized illustration ofTLRs and their ligands.TLR are
key initiators of inﬂammation during host defense. Acting as dimers, the ten
different TLRs display differential patterns of recognition of microbial
products. TLR4 detects LPS, which is speciﬁc to Gram-negative species.
TLR1/2 andTLR2/6 recognize triacylated and diacylated polypeptides,
respectively, from mycobacteria. TLR5 responds to ﬂagellin from the ﬂagella
of multiple bacteria. TLR7 andTLR8 detect single-stranded RNA (ss-RNA)
from viruses, andTLR9 detects CpG DNA, which is common in bacterial and
viral pathogens. TLR3 recognizes double-stranded RNA (ds-RNA) or synthetic
compounds such as Poly I:C.
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FIGURE 3 | EssentialTLR-associated signaling pathways and cytokine
production. Upon ligand stimulation, all TLRs, except TLR3, recruit the
adaptor MyD88. In turn, MyD88 binds to a protein complex composed of
IRAK4, IRAK1, andTRAF6. TRAF6 undergoes self-polyubiquitination resulting
in the phosphorylation of TAK1. In turn, TAK1 activates IKK complex that leads
to the phosphorylation, ubiquitination, and degradation of IκBα. This allows
NF-κB to translocate into the nucleus. Simultaneously, theTAK1-containing
complex activates the p38 MAP kinase pathway triggering the activation of
AP-1. Together, NF-κB and AP-1 induce the expression of pro-inﬂammatory
cytokines. TLR4 andTLR2, in combination with TLR1 or TLR6, recruit TIRAP
that serves as a link adaptor for the recruitment of MyD88. Moreover, TLR4
recruits a second link adaptor namedTRAM that allows interaction with the
adaptor TRIF. Upon stimulation with an agonist, TLR3 recruits TRIF.
TRIF-mediated activation of NF-κB and AP-1 also occurs through a
TRAF6-dependent pathway. Upon stimulation, TRIF also bindsTRAF3, which
activates TBK. TBK phosphorylates IRF3 and permits its homodimerization
and nuclear translocation. IRF-3, along with NF-κB and AP-1, cooperate to
induce the expression of type I IFNs. AP-1, activator protein-1; CBP, cyclic
AMP response element binding factor binding protein; IκB-α, inhibitor of
NF-κB -α; IKK, IκB kinase complex; IRF, interferon regulatory factor; IRAK, IL-1
receptor-associated kinase; NF-κB, nuclear factor kappa light chain enhancer of
activated B cells; p38MAPK, p38 mitogen activated protein kinase; TAB, TAK1
binding protein; TBK, TANK(TRAF family member NF-κB activator) -binding
kinase; TAK1, TGF-1β activated kinase 1; TRAF, TNF receptor associated factor.
a ligand of F protein of RSV can activate MyD88-dependent sig-
naling pathways resulting in the production of Th1 cytokines such
as TNF-α, IL-6, IL-8, IL-12, and IL-18 (See and Wark, 2008; Klein
Klouwenberg et al., 2009). On the other hand, TLR-3 activates
MyD88 independent pathways leading to the production of IFN-
1β (Akira, 2003; McGettrick and O’Neill, 2004; Takeda and Akira,
2004).
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN FAMILY
AND CYTOKINE PRODUCTION
In macrophages and epithelial cells, NLRs play a pivotal role
in the recognition of bacteria and viruses as PRR molecules
(Figure 1; Wells et al., 2011). At present, about 20 types of
NLRs have been conﬁrmed in humans (Schroder and Tschopp,
2010). The representative pathogen PRR-related NLRs are NLRP1,
NLRP3 (cryopyrin), and NLRPC4 (Schroder and Tschopp, 2010).
These molecules have both signal transduction domains in the
N-terminal and leucine-rich repeats in the C-terminal (Schroder
and Tschopp, 2010). Thus, NLRs show the properties of both PRR
molecules and signaling molecules (Schroder and Tschopp, 2010).
In addition, the N-terminal of NLRs acts as a caspase recruit-
ment domain (CARD; Schroder and Tschopp, 2010). For example,
NLRP3 binds pro-caspase-1 through activation of TLRs (TLR4)
and forms “inﬂammasome” (Bauernfeind and Hornung, 2013).
Activated NLRP3-pro-caspase-1 complex releases active caspase-1
(Schroder and Tschopp, 2010; Bauernfeind and Hornung, 2013).
Active type caspase-1 activates pro-IL-1β and pro-IL-18, lead-
ing to their production in the cells (Schroder and Tschopp, 2010;
Bauernfeind and Hornung, 2013).
RETINOIC ACID-INDUCIBLE GENE-I LIKE RECEPTORS FAMILY
Retinoic acid-inducible gene-I and MDA5 (melanoma differen-
tiation-associated protein 5) are localized in the cytosol and may
be able to bind to some ssRNA viruses such as RSV, inﬂuenza virus,
dengue fever viruses (DFV), and hepatitis C virus, leading to the
production of type I IFN (IFN-α/β) in ﬁbroblasts (Breiman et al.,
2005; Loo et al., 2008; Jamaluddin et al., 2009; Bustos-Arriaga et al.,
2011). In particular, it is known that RIG-I binds to ssRNA (5′-
triphosphate RNA) derived from inﬂuenza virus and induces type
I IFN (Loo et al., 2008). Furthermore, both RIG-I and MDA5 can
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bind to DFV type 2 genome and induce the production of type I
IFN (Qin et al., 2011a). However, the roles of these molecules in
innate immunity are not known at present.
INFLAMMASOME, RLR-ASSOCIATED SIGNALING
PATHWAYS, AND CYTOKINE PRODUCTION
Inﬂammasome as a PRR is a concept of the inﬂammatory
reaction-associated protein complex (Schroder and Tschopp,
2010). It is suggested that both RIG-I and MDA5 can bind
to an adaptor molecule, IPS-1(interferon-1β promoter stimu-
lator 1), and activate NF-κB, resulting in the production of
type I IFN (Schroder and Tschopp, 2010; Bauernfeind and
Hornung, 2013). Inﬂammasome is composed of some protein
complexes such as Apaf-1(apoptotic protease-activating factor
1), ASC (apoptosis-associated speck-like protein containing cas-
pase recruitment domain), NOD (nucleotide-binding domain),
and NALP (NACHT, LRR and PYD domain-containing protein;
Schroder and Tschopp, 2010; Bauernfeind and Hornung, 2013).
The complex recognizes various components of pathogens and
uric acid as“danger signals”(Schroder andTschopp,2010; Bauern-
feind and Hornung, 2013). After recognition of the signals, these
signals activate ASC, leading to the conversion of procaspase-1 to
caspase-1 (Schroder and Tschopp, 2010; Bauernfeind and Hor-
nung, 2013). The protease caspase-1 activates proinﬂammatory
cytokine precursors such as pro-IL-1β and pro-IL-18, leading
to conversion to active forms of IL-1β and IL-18 (Schroder and
Tschopp, 2010; Bauernfeind and Hornung, 2013). Interestingly,
very recent studies suggest that various inﬂammatory diseases
such as atherosclerosis and rheumatoid arthritis are associated
with inﬂammasome, although the precise mechanisms are not
known.
RELATIONSHIPS BETWEEN PRRs, SIGNALING PATHWAYS,
AND CYTOKINE PRODUCTION IN RESPIRATORY
VIRUS-INFECTED CELLS
In general, cytokine production in immunological cells such
as lymphocytes may be induced through each cytokine recep-
tor on the cells (Salek-Ardakani and Croft, 2010; Rossol et al.,
2011). Certainly, this process may occur in virus-infected cells
(He and Greenberg, 2002). As mentioned previously, cytokine
production may trigger innate immunity through PRRs including
TLRs, RLRs, and inﬂammasomes (NLRPs-pro-caspase-1 complex;
Figure 1; Yu and Levine, 2011). These receptors and/or intracel-
lular protein complexes induce phosphorylation of the signaling
molecules. Although the precise mechanisms are not known,
the phosphorylation cascades of the molecules lead to cytokine
production in virus-infected cells (Yu and Levine, 2011). The rep-
resentative data of virus infection-associated signaling pathways
is shown in Figure 4. Brieﬂy, a previous report showed that RSV
infection in human fetal lung ﬁbroblasts (MRC-5 cells) induces
various cytokines through the activation (phosphorylation) of
Akt (murine thymoma viral oncogene homolog/protein kinase
B), p38MAPK (mitogen activated protein kinase), ERK1/2 (extra-
cellular signal-regulated kinase), and IκB-α (Seki et al., 2013).
Human rhinovirus (HRV) infection in human bronchial epithe-
lium cells (BEAS-2B cells) activated p38MAPK, ERK1/2, and
NF-κB (nuclear factor kappa B protein). Human parainﬂuenza
virus (HPIV) infection in MRC-5 cells activated p38MAPK and
IκB-α (Yoshizumi et al., 2010). However, it is not currently known
how PRRs are associated with the production of these cytokines.
RESPIRATORY VIRUS INFECTION-ASSOCIATED CYTOKINE
PRODUCTION
The summarized data of the cytokine production proﬁles in some
respiratory virus-infected cells are shown in Table 1. Numerous
reports show that most respiratory virus infections can induce
the production of various types of cytokines in vitro and in vivo
(Khaitov et al., 2009; Koetzler et al., 2009; Martínez et al., 2009;
Sharma et al., 2009; Ishioka et al., 2011; Lewis et al., 2012; Seki
et al., 2013). The ﬁndings of previous in vitro studies suggest that
inﬂuenza virus type A [subtype A(H1N1) virus]-infected human
airway epithelial cells produces signiﬁcant amounts of IL-1, IL-6,
and IL-8 (Hofmann et al., 1997). Production is associated with
inﬂammasome (NLRP3-pro-caspase-1 complex; Pothlichet et al.,
2013). HRV-infected airway epithelial cells produced IL-1, IL-6,
IL-8, RANTES (regulated on activation normal T cell expressed
and secreted), eotaxin, interferon-inducible protein (IP)-10, IL-11,
TNF-α, granulocyte macrophage colony-stimulating factor (GM-
CSF), IFN-1β, and IFN-λ (Yamaya, 2012). RSV-infected airway
epithelial cells produced IL-1, IL-4, PIV-3, IL-6, RANTES, IL-
8, IL-11, GM-CSF, andTNF-α (Yamaya, 2012). HPIV-3 infected
human lung ﬁbroblasts induced excessive expression of IL-1β,
IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-10, G-CSF, GM-CSF, IFN-γ,
TNF-α, IL-8 IP-10, eotaxin, and RANTES (Yoshizumi et al.,
2010).
Previous in vitro studies have demonstrated that elevated
IL-6, IL-8, and RANTES are found in sputum and serum in
inﬂuenza virus infection (Yamaya, 2012). IL-6 and IL-8 were ele-
vated in sputum and serum in HRV infection (Yamaya, 2012).
Systemic avian inﬂuenza virus [subtype A(H5N1) virus] infec-
tion induced excessive production of proinﬂammatory cytokine,
namely a cytokine storm (Ramos and Fernandez-Sesma, 2012).
These results imply that cytokine production proﬁles may
vary. Although the detailed information of the signaling path-
ways is not yet known, these differences may be associated
with the pathophysiology of each respiratory virus infection
(Schwarze and Mackenzie, 2013).
RELATIONSHIP BETWEEN CYTOKINE PRODUCTION DUE TO
RESPIRATORY VIRUS INFECTION AND THE
PATHOPHYSIOLOGY OF VIRUS-INDUCED ASTHMA
Viral infections clearly induce inﬂammation at infected sites. A
variety of complicated pathophysiological events occur at these
sites. In broad terms, these events may constitute converged
cell death and regeneration (Rennard and von Wachenfeldt,
2011). The process of events has been named “remodeling”
(Al-Muhsen et al., 2011). Cytokines derived from respiratory
virus infections may be associated with airway remodeling
(Kuo et al., 2011). It is suggested that the major production
sources of cytokines are airway epithelium, ﬁbroblasts, myoﬁ-
broblasts, and leukocytes within infected regions (Westergren-
Thorsson et al., 2010). These cytokines may be associated
with remodeling processes following respiratory virus infections
(Holtzman et al., 2002).
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FIGURE 4 | PRRs and virus infection-associated signaling pathways.
The innate immune response to the fusion protein of an important
respiratory pathogen of humans, RSV, is mediated byTLR4. The RSV F
protein induces translocation of TLR4 to the endosome together with
TRAM.TLR3 is expressed in intracellular endosomes and responds to the
presence of double-stranded RNA (dsRNA), which forms as a product of the
replication of the majority of RNA viruses such as RSV. TLR3 andTLR4
activate TRIF-dependent signaling, which activates NF-κB and IRF-3,
and results in the induction of proinﬂammatory cytokines and
type I IFNs. Moreover, TLR4 is able to signal via both MyD88-dependent
and -independent pathways and is able to activate a response via IRF-3,
NF-κB, AP-1, ERK and IKK. These receptors recognize RSV and induce an
appropriate antiviral innate immune response in the infected cells. Akt,
protein kinase B; ERK1/2, extracellular signal regulating kinase1/2; PDK1,
phosphoinositide-dependent kinase 1; PI3K: phosphatidylinositol-3
kinase.
Table 1 | Cytokines and chemokines induced by virus infection.
Viruses Samples and
specimens
Cytokines and chemokines Reference
RSV A549 GM-CSF Ishioka et al. (2011)
MRC-5 IL-1β, IL-6, TNF-α, IL-1ra, IFN-γ, IFN-λ1a, IL-2, IL-12, IL-4, IL-5,
IL-10, IL-13, G-CSF, GM-CSF, eotaxin, RANTES, IL-8, IP-10,
MCP-1, MIP-1α, PDGF-bb, VEGF, FGF-basic
Seki et al. (2013)
HEp-2 IL-1β, MCP-1, MIP-1α, RANTES Martínez et al. (2009)
Primary BECs IFN-β, IFN-λ1 Khaitov et al. (2009)
HRV Nasal aspirates IFN-γ, IL-6, IL-8, IP-10, eotaxin, RANTES Lewis et al. (2012)
BEAS-2B IL-6, TNF-α, IL-8, IP-10 Koetzler et al. (2009),
Sharma et al. (2009)
PIV MRC-5 IL-1β, IL-6, TNF-α, IL-1ra, IFN-γ, IL-2, IL-4, IL-5, IL-10, G-CSF,
GM-CSF, eotaxin, RANTES, IL-8, IP-10, PDGF, VEGF
Yoshizumi et al. (2010)
RSV, respiratory syncytial virus; HRV, human rhinovirus; PIV, parainﬂuenza virus.
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CONCLUSION
Since the discovery of PRRs, remarkable progress has been
made toward understanding the role of innate immunity against
pathogens. However, the precise roles of PRRs, the mechanisms of
intrinsic signaling pathways, and cytokine production with regard
to PRRs are not fully understood. In addition, recent studies
suggest that PRRs may be associated with various inﬂammatory
diseases such as gout, rheumatoid arthritis, and atherosclerosis. It
would be beneﬁcial to clarify the functional relevancy of infectious
diseases and other inﬂammatory diseases in the near future.
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